Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Colorectal Cancer Reports|March 23, 2011
Fecal Tests: From Blood to Molecular MarkersGraeme P Young, Linda J W Bosch
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|May 30, 2009
Basic fibroblast growth factor-mediated overexpression of vascular endothelial growth factor in 1F6 human melanoma cells is regulated by activation of PI-3K and p38 MAPKDennis Fontijn, Linda J W Bosch, Monique C A Duyndam, et al.
Clinical Colorectal Cancer|May 26, 2011
Molecular tests for colorectal cancer screeningLinda J W Bosch, Beatriz Carvalho, Remond J A Fijneman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2017
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer ScreeningIris Lansdorp-Vogelaar, S Lucas Goede, Linda J W Bosch, et al.
Plos One|December 31, 2021
Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme BAnneleen Daemen, Akshata R Udyavar, Thomas Sandmann, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 24, 2012
Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detectionLinda J W Bosch, Sandra Mongera, Jochim S Terhaar Sive Droste, et al.
JCO Precision Oncology|October 11, 2021
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung CancerRobert D Schouten, Daan C L Vessies, Linda J W Bosch, et al.
Scientific Reports|May 16, 2018
Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancerAnnika Jacobsen, Linda J W Bosch, Sanne R Martens-de Kemp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical DiagnosticsKarlijn Hummelink, Renaud Tissier, Linda J W Bosch, et al.
Carcinogenesis|March 31, 2009
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21Sarah Derks, Linda J W Bosch, Hanneke E C Niessen, et al.
Pageof 3